http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108794414-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D251-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D251-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D251-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D251-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate | 2018-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-01-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-01-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-108794414-B |
titleOfInvention | Aromatic amido substituted s-triazine compound, preparation and application thereof |
abstract | The invention provides an aromatic amido substituted triazine compound, which is prepared by mixing a 2-amino-1, 3, 5-triazine compound and a cyanogen compound, adding the mixture into a solvent, reacting under the action of a copper catalyst, and post-treating reaction liquid. The method has the advantages of mild reaction conditions, easily obtained raw materials, convenient operation, low cost and wide industrial application prospect. The aromatic amide substituted s-triazine compound provided by the invention shows certain activity of resisting human osteosarcoma cells, can be applied to preparation of antitumor drugs, and particularly applied to preparation of drugs for treating osteosarcoma, and has a structural general formula as follows: |
priorityDate | 2018-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 82.